A Pilot Study of Docosahexaenoic Acid (DHA) in Obese Menopausal Women

NCT ID: NCT01127867 Phase: NA Status: COMPLETED Enrollment: 17 Completion: 2013-04

Conditions

Breast Cancer, Obesity

Interventions

dietary intervention

Summary

This study aims to determine if a supplement of an omega-3-fatty acid (docosahexaenoic - DHA) lowers inflammation in human fat tissue thereby lowering estrogen production and the potential risk for breast cancer. The investigators also aim to study how this occurs to discover the basis for other potential treatments to lower estrogen production in fat tissue and decrease the risk of breast cancer.

Primary Outcome

Reduced subcutaneous fat (obese)

Source

ClinicalTrials.gov